Alice McPherson | |
Birth Date: | 20 June 1926 |
Birth Place: | Saskatchewan |
Workplaces: | Massachusetts Eye and Ear University of Wisconsin–Madison |
Alma Mater: | University of Wisconsin–Madison |
Alice McPherson (June 20, 1926 – January 16, 2023) was a Canadian-born physician and professor who dedicated her career to the diagnosis and treatment of retinal disease. She founded the Retina Research Foundation and the McPherson Eye Research Institute. She was awarded the University of Lausanne Gonin Medal in 2014.
McPherson was born in Saskatchewan.[1] She spent her childhood in Minnesota and Wisconsin. She studied medicine at the University of Wisconsin–Madison, and completed a residency in ophthalmology in 1955.[2] She said that she chose to specialise in ophthalmology because she realised how important vision was to wellbeing. She was a fellow with Charles Schepens at Massachusetts Eye and Ear. At the time she was training, there were not many cures for retinal detachment. McPherson was the first woman fellow to work in vitreoretinal surgery.[3]
In 1958, McPherson moved to Texas, where she joined the Baylor College of Medicine. She pioneered several procedures in retinal surgery, including cryotherapy, laser photocoagulation and serial buckling.[4] She was a proponent of photocoagulation in the treatment of diabetic retinopathy.[5] She became the first woman to be accepted to the European Jules Gonin club.
In 1969, McPherson founded the Retina Research Foundation, which looked to eradicate retinal disease worldwide. The Foundation provided funding to researchers working on retinal diseases and established professorships at major research institutions. From 1969 to 2023 the foundation awarded over $40 million to researchers working in ophthalmology. In 2002 McPherson helped to establish the University of Wisconsin Eye Research Institute, which became known as the McPherson Eye Research Institute in her honour in 2012. She served on their Board of Directors.
In 1969, McPherson founded the Retina Research Foundation, which would become one of the leading eye research organisations in the word.[6]